Xiaowei Yan
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Blood Pressure and Hypertension Studies 5
-
- COVID-19 Clinical Research Studies 11
- Co-authors
- Shuyang Zhang (13 shared papers)Taisheng Li (7 shared papers)Zhengyin Liu (6 shared papers)Jinglan Wang (6 shared papers)Yan Qin (4 shared papers)Wen Zhang (1 shared paper)Qian Wang (1 shared paper)Xiaofeng Zeng (1 shared paper)
- Journals
- Atherosclerosis (3 papers)Journal of Cardiovascular Pharmacology (3 papers)Scientific Reports (2 papers)Clinical Immunology (2 papers)Current Medical Research and Opinion (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Xiaowei Yan
93 papers receiving 4.9k citations
Xiaowei Yan's Hit Papers
Peers
Comparison fields: 5 of 134
- Infectious Diseases 2.2k
- Internal Medicine 124
- Computational Mathematics 25
- Neurology 416
- Rheumatology 324
Countries citing papers authored by Xiaowei Yan
This map shows the geographic impact of Xiaowei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Yan more than expected).
Fields of papers citing papers by Xiaowei Yan
This network shows the impact of papers produced by Xiaowei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Yan. The network helps show where Xiaowei Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowei Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 Hit paper breakdown → | 2020 | 1742 |
| 2 | The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China Hit paper breakdown → | 2020 | 1023 |
| 3 | Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction Hit paper breakdown → | 2019 | 427 |
| 4 | 2020 | 149 | |
| 5 | 2020 | 144 | |
| 6 | 2020 | 126 | |
| 7 | 2020 | 88 | |
| 8 | 2014 | 79 | |
| 9 | 2020 | 79 | |
| 10 | 2021 | 79 | |
| 11 | 2013 | 76 | |
| 12 | 2020 | 65 | |
| 13 | 2011 | 60 | |
| 14 | 2010 | 54 | |
| 15 | 2019 | 44 | |
| 16 | 2009 | 38 | |
| 17 | 2024 | 34 | |
| 18 | 2020 | 33 | |
| 19 | 2020 | 30 | |
| 20 | 2015 | 28 |
About Xiaowei Yan
Xiaowei Yan is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Surgery, Family Practice and Health Information Management, having authored 98 papers that have together received 5k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (11 papers), COVID-19 Clinical Research Studies (11 papers), Lipoproteins and Cardiovascular Health (10 papers), Blood Pressure and Hypertension Studies (5 papers), Medication Adherence and Compliance (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Electronic Health Records Systems (4 papers) and Machine Learning in Healthcare (3 papers). The work is most often cited by research in Infectious Diseases (2.2k citations), Internal Medicine (124 citations), Computational Mathematics (25 citations), Neurology (416 citations) and Rheumatology (324 citations). Xiaowei Yan has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Shuyang Zhang, Taisheng Li, Zhengyin Liu, Jinglan Wang, Yan Qin, Wen Zhang, Qian Wang, Xiaofeng Zeng, Fengchun Zhang and Xuan Zhang. Their work appears in journals such as Atherosclerosis, Journal of Cardiovascular Pharmacology, Scientific Reports, Clinical Immunology and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.